CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Charles River Laboratories International, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • Charles River Laboratories International, Inc. Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was $25.4M, a 13.1% decline year-over-year.
  • Charles River Laboratories International, Inc. Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was $94.5M, a 31.3% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2023 was $101M, a 22.6% decline from 2022.
  • Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2022 was $130M, a 59.2% increase from 2021.
  • Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2021 was $81.9M, a 0.08% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $94.5M $25.4M -$3.83M -13.1% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $98.4M $24.5M -$2.56M -9.44% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $101M $19.8M -$36.1M -64.6% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 $137M $24.9M -$643K -2.52% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $138M $29.2M -$4.23M -12.6% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 $142M $27.1M +$11.5M +73.4% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 $130M $55.8M +$32M +134% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $98.4M $25.5M +$7.38M +40.8% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 $91M $33.4M -$4.13M -11% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 $95.1M $15.6M +$13.3M +560% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 $81.9M $23.8M -$4.42M -15.7% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 $86.3M $18.1M -$14.6M -44.6% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 $101M $37.6M +$21.3M +131% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 $79.6M $2.37M -$2.26M -48.8% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 $81.8M $28.2M +$3.18M +12.7% Sep 27, 2020 Dec 26, 2020 10-K 2023-02-22
Q3 2020 $78.6M $32.7M +$33M Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 $45.6M $16.3M +$1.6M +10.9% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 $44M $4.62M -$5.98M -56.4% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 $50M $25.1M +$10.2M +68.7% Sep 29, 2019 Dec 28, 2019 10-K 2022-02-16
Q3 2019 $39.8M -$317K -$12.7M -103% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-09
Q2 2019 $52.5M $14.7M -$2.75M -15.8% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-05
Q1 2019 $55.3M $10.6M +$830K +8.49% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-07
Q4 2018 $54.5M $14.9M -$83.2M -84.9% Sep 30, 2018 Dec 29, 2018 10-K 2021-02-17
Q3 2018 $138M $12.4M -$7.54M -37.8% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-06
Q2 2018 $145M $17.4M -$4.81M -21.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $150M $9.77M -$21.3M -68.6% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $171M $98.1M +$79.6M +432% Oct 1, 2017 Dec 30, 2017 10-K 2020-02-11
Q3 2017 $91.7M $19.9M +$4.38M +28.1% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $87.3M $22.2M +$3.4M +18% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $83.9M $31.1M +$17.1M +122% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-10
Q4 2016 $66.8M $18.5M +$1.72M +10.3% Sep 25, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $65.1M $15.6M +$310K +2.03% Jun 26, 2016 Sep 24, 2016 10-Q 2017-11-09
Q2 2016 $64.8M $18.8M +$7.77M +70.1% Mar 27, 2016 Jun 25, 2016 10-Q 2017-08-09
Q1 2016 $57M $14M +$13.6M +4122% Dec 27, 2015 Mar 26, 2016 10-Q 2017-05-10
Q4 2015 $43.4M $16.7M +$5.08M +43.6% Sep 27, 2015 Dec 26, 2015 10-K 2018-02-13
Q3 2015 $38.3M $15.3M +$3.67M +31.7% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-02
Q2 2015 $34.6M $11.1M -$3.01M -21.3% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-03
Q1 2015 $37.6M $331K -$10M -96.8% Dec 28, 2014 Mar 28, 2015 10-Q 2016-05-04
Q4 2014 $47.7M $11.7M +$8.07M +225% Sep 28, 2014 Dec 27, 2014 10-K 2017-02-14
Q3 2014 $39.6M $11.6M +$192K +1.69% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 $39.4M $14.1M +$5.86M +71.3% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 $33.5M $10.4M +$636K +6.54% Dec 29, 2013 Mar 29, 2014 10-Q 2015-04-30
Q4 2013 $32.9M $3.58M +$92K +2.64% Sep 29, 2013 Dec 28, 2013 10-K 2016-02-12
Q3 2013 $32.8M $11.4M +$5.38M +89.5% Jun 30, 2013 Sep 28, 2013 10-Q 2014-10-30
Q2 2013 $27.4M $8.22M -$1.23M -13.1% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-07
Q1 2013 $28.7M $9.72M +$1.05M +12.1% Dec 30, 2012 Mar 30, 2013 10-Q 2014-04-30
Q4 2012 $27.6M $3.49M -$2.09M -37.4% Sep 30, 2012 Dec 29, 2012 10-K 2015-02-17
Q3 2012 $29.7M $6.01M +$381K +6.77% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $29.3M $9.45M +$804K +9.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $28.5M $8.68M +$11.4M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $17.1M $5.58M Sep 25, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $5.63M -$11M -66.2% Jun 26, 2011 Sep 24, 2011 10-Q 2012-11-01
Q2 2011 $8.65M +$1.48M +20.6% Mar 27, 2011 Jun 25, 2011 10-Q 2012-08-07
Q1 2011 -$2.72M -$9.45M -140% Dec 26, 2010 Mar 26, 2011 10-Q 2012-05-04
Q3 2010 $16.7M Jun 27, 2010 Sep 25, 2010 10-Q 2011-11-02
Q2 2010 $7.17M Mar 28, 2010 Jun 26, 2010 10-Q 2011-08-03
Q1 2010 $6.74M Dec 27, 2009 Mar 27, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.